26 THE ENZYME TREATMENT OF CANCER
cancer cells (in the test-tube). Nor have I ever held, as some have done, that because they supposed, erroneously, that trypsin had some action in “ splitting up” glycogen or animal starch, that it “ dissolved” glycogen, therefore it should be used in cancer cases. From the start I wished all the ferments—trypsin, amylopsin, and steapsin—of the pancreas gland to be used in the injections employed,* The import of trypsin was, of course, clear, for it was known, since the work of Corvisart and Kühne, to attack and pull down dead l-albumins, and I anticipated—rightly, in spite of all the contradictions extant, which are false—that it would, and scientifically regarded must, pull down the living d-albumins of cancer or trophoblast.** The special reasons for the employment of very potent injections of amylopsin, which normally converts starch into a d-sugar, termed “glucose,” came later on. It was found that the injections first used, which were very deficient in amylopsin, being sometimes, indeed, almost chemically pure trypsin, produced after some six to eight weeks, according to the strengths employed, very bad symptoms. These were first reported to me by French and Italian physicians, and I told them that, as this treatment followed the lines of what happened in a normal human gestation from the seventh week onwards, they
* For evidence of this, reference need only be made to the following fact: Early in 1906, when the London representative of a well-known firm of manufacturing chemists, specialists in the ferments, called upon me, I requested him to inform his firm that in my opinion the injections for use in cancer ought to contain all the ferments.
** The evidences of the truth of this will be found in the text under the description of the course of the York case. The like facts were also witnessed in the very similar course of the Naples case, and these scientific finds are confirmed up to the hilt by the facts concerning the “liquefaction of cancer ‘‘ in the living human body, as detailed subsequently.